CD34 and brain neoplasm: Zhang et al. (2017) did not find any significant correlations between the BRAF status in GNT and postoperative seizure freedom. Also, Xing et al. (2021) reported there was no statistical difference of epilepsy-associated brain tumors between BRAFV600E mutations and wild type in Engel outcome comparison. Similarly, we defined no differences between CD34 expression (p = 0.807) or BRAFV600E mutation (p = 0.937) in GG and postoperative seizure outcomes (Figure 3).